1 min readBy Catherine Tomlinson for Spotlight
SPOTLIGHT: Is Aspen right to abandon lenacapavir for an unproven HIV prevention pill?
%2Ffile%2Fattachments%2Forphans%2FMC-TrailblazerMatsoso1_236101.jpg?w=900&fmt=webp&q=80&fit=cover)
Aspen Pharmacare has announced that it will not be manufacturing the lenacapavir HIV prevention injection, and that it will instead focus on producing alimatravir, an experimental HIV prevention pill.
Follow the story
About this article
- Length
- 29 words · 1 min read
- Published
- September 23, 2026
- Byline
- Catherine Tomlinson for Spotlight
- Source
- Daily Maverick